Advertisement
UK markets closed
  • FTSE 100

    8,381.35
    +27.30 (+0.33%)
     
  • FTSE 250

    20,531.30
    +39.31 (+0.19%)
     
  • AIM

    783.70
    +3.87 (+0.50%)
     
  • GBP/EUR

    1.1610
    -0.0013 (-0.11%)
     
  • GBP/USD

    1.2506
    +0.0009 (+0.07%)
     
  • Bitcoin GBP

    49,744.77
    -2.54 (-0.01%)
     
  • CMC Crypto 200

    1,334.80
    +34.70 (+2.67%)
     
  • S&P 500

    5,199.45
    +11.78 (+0.23%)
     
  • DOW

    39,220.32
    +163.93 (+0.42%)
     
  • CRUDE OIL

    79.01
    +0.02 (+0.03%)
     
  • GOLD FUTURES

    2,336.60
    +14.30 (+0.62%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • DAX

    18,686.60
    +188.22 (+1.02%)
     
  • CAC 40

    8,187.65
    +56.24 (+0.69%)
     

FTSE 100 hits 12 month high as vaccine hopes buoy blue-chip index

 (Anglo American)
(Anglo American)

The FTSE 100 hit its highest level in over a year this morning trading above 6,920 at its highest since the pandemic struck and global stock markets plunged.

Johnson Matthey moved into pole position in the FTSE 100 Index today as the maker of catalytic converters revealed more detail on its plans in the clean air arena.

One in every three new cars carries one of JM’s converters, but with the transition towards electric vehicles well under way the blue-chip company is increasingly pivoting its business toward supplying materials for batteries and hydrogen fuel cells.

The need to drive cashflow from its more established operations towards these newer sustainable technologies means JM has started a review of its Health business, which makes ingredients for opioid addiction therapies.

ADVERTISEMENT

As well as the review announced today, the chemicals company also told investors that the recent rebound in activity in auto manufacturing should mean its performance for the year to last month will be towards the top end of City expectations.

Shares jumped by 3% to 3,205p at the top of the FTSE 100 index risers board today, with sentiment further boosted by the promise that the review of the Health business will focus on maximising value for shareholders.

WATCH: Global Market Cues | Gold traded around multi-month lows under $1,700 per ounce

Hargreaves Lansdown analyst Laura Hoy said: “We wonder if potential sale proceeds would be used to ramp up its electric vehicle transition, or if management is hoping to unearth a new growth opportunity outside autos. The former makes sense, considering Johnson Matthey’s entrenchment in the auto industry.”

Other industrial stocks joined JM on the way up today, with software business Aveva the next biggest riser after lifting 87p to 3,717p.

Economic recovery hopes have boosted sentiment towards mining stocks in particular, with Anglo American up another 43.5p to 3,031.5p after it revealed plans to demerge its thermal coal business in South Africa.

AJ Bell analyst Danni Hewson said the move showed miners continuing their transition from being contributors to climate change to playing a critical role in sourcing the materials required for renewables and electric vehicle infrastructure.

The FTSE 250 is also at a record high – up 1.44 points higher at 22,162.01, with some of the stocks behind yesterday’s rally to a record high trading lower. They included cruise ship company Carnival, which fell 70.8p to 1728.2p.

WATCH: How to prevent getting into debt

Read More

Experts pick best stocks to watch as FTSE 250 hits all-time high

FTSE100 nears record high as fear over Oxford vaccine weighs on pound

FTSE250 stocks hit record high as economic optimism sweeps markets

5 ways to update your home this spring – with help from TikTok